Exchange: NASDAQ·Updated 08:46 AM EDT

TRXB Trex Bio Inc.

$13.50
$0.02
(0.15%)
Pre-Market
Prev Close $13.52
Mkt Cap$371.07M
Vol12.00

About TRXB

Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory diseases. It focuses on studying the regulation of tissue inflammation to develop breakthrough medicines. The company was founded by Houman Ashrafian, Adil Daud, Wilson Liao, Diane Mathis, Drew Pardoll, Michael Rosenblum, Alison Simmons, and Jim Wells in May 24, 2018 and is headquartered in South San Francisco, CA.
45

Neutral Sentiment

How do you feel about TRXB?

Advertisement|Remove ads.